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Abstract 18 
Mycotoxin contamination of cereal grains causes well-recognized toxicities in animals and 19 
humans, but the fate of plant-bound masked mycotoxins in the gut is less well understood. 20 
Masked mycotoxins have been found to be stable under conditions prevailing in the small 21 
intestine, but are rapidly hydrolyzed by fecal microbiota. This study aims to assess the 22 
hydrolysis of the masked mycotoxin deoxynivalenol-3-glucoside (DON3Glc) by microbiota of 23 
different regions of the porcine intestinal tract. 24 
Intestinal digesta samples were collected from the jejunum, ileum, caecum, colon and feces of 25 
5 pigs and immediately frozen under anaerobic conditions. Sample slurries were prepared in 26 
M2 culture medium, spiked with DON3Glc or free DON (2 nmoles/mL) and incubated 27 
anaerobically for up to 72 hours. Mycotoxin concentrations were determined using LC-MS/MS 28 
and microbiota composition was determined using qPCR methodology.  29 
Jejunal microbiota hydrolyzed DON3Glc very slowly, while samples from the ileum, caecum, 30 
colon and feces rapidly and efficiently hydrolyzed DON3Glc. No further metabolism of DON 31 
was observed in any sample. Microbial load and microbiota composition was significantly 32 
different in the ileum, but similar in caecum, colon and feces.  33 
 34 
Importance 35 
Results from this study clearly demonstrate that the masked mycotoxin DON3Glc is 36 
hydrolyzed efficiently in the distal small intestine and large intestine of pigs. Once DON is 37 
released, toxicity and absorption in the distal intestinal tract are likely to occur in vivo. This 38 
study further supports the need to include masked metabolites into mycotoxin risk assessments 39 
and regulatory actions for feed and food. 40 
  41 
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Introduction 42 
Mycotoxin contamination of agricultural commodities is an intractable problem globally. In 43 
temperate climates Fusarium fungi comprise the most important mycotoxin producers and are 44 
particularly prevalent in small grain cereals such as wheat and barley as well as maize. The 45 
major groups of Fusarium mycotoxins include trichothecenes, zearalenone and fumonisins [1]. 46 
In addition to the well described trichothecenes deoxynivalenol (DON), nivalenol, T2 toxin 47 
and HT2 toxin, cereals have been found to be co-contaminated with plant-derived mycotoxin 48 
metabolites, so-called masked mycotoxins. In response to fungal infection and mycotoxin 49 
production, the plant’s own phase II metabolic enzymes conjugate mycotoxins with small 50 
molecules such as glucose, glutathione or sulphate and sequester these masked mycotoxins into 51 
the plant cell vacuole (for review see [2-4]). Mycotoxins and masked mycotoxins are stable 52 
compounds withstanding processing into various cereal products and are carried over into 53 
finished food and feed. Once ingested, mycotoxins have been shown to be rapidly absorbed in 54 
the small intestine of humans and various animal species and exert their toxicities either locally 55 
on the gut epithelium (e.g. trichothecenes) or systemically (e. g. zearalenone) [1,4-6]. Masked 56 
mycotoxins such as DON-3-β,D-glucoside (DON3Glc) on the other hand, are far less toxic 57 
compared to their free parent mycotoxins and are not absorbed intact [7-9]. Hence masked 58 
mycotoxins are transported into the distal parts of the intestine intact where the intestinal 59 
microbiota (as studied using fecal samples) rapidly hydrolyze masked mycotoxins and release 60 
free mycotoxins [7,10-12]. Microbial metabolism experiments have also demonstrated further 61 
metabolism of DON to de-epoxy DON (DOM-1) by microbiota samples derived from 62 
chickens, pigs, and some humans [10,13,14]. This purely microbial metabolite, DOM-1, is not 63 
toxic [15] and can be found in urine of some humans [10,16,17] and pigs [18] hence confirming 64 
its production and colonic absorption in vivo. 65 
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In pigs oral bioavailability and absorption of DON3Glc is significantly lower and slower, 66 
compared to DON [18,19]. The delay in DON3Glc absorption and the fact that only free DON 67 
and no DON3Glc are found in plasma and urine, confirm that the hydrolysis and absorption 68 
occur in the more distal parts of the intestinal tract compared to free DON. Microbial de-69 
epoxidation of DON or DON3Glc by pig microbiota has been found in some studies [14,18] 70 
but not in others [19]. 71 
All studies published to date have used fecal samples from pigs or humans to determine 72 
microbial hydrolysis and metabolism of mycotoxins. However, microbial metabolism of 73 
mycotoxins would need to occur in more proximal parts of the intestinal tract to release 74 
mycotoxin metabolites and allow intestinal absorption and/or potential colonic toxicity to 75 
occur. Therefore, the aim of this study was to investigate the capacity of intestinal microbiota 76 
derived from different regions of the small and large intestine of pigs to degrade masked 77 
mycotoxins. For this study, DON3Glc was used as model mycotoxin as it is commercially 78 
available. 79 
 80 
Materials and Methods 81 
The following mycotoxin standards were used in this study: DON as powder (Molekula, 82 
Gillingham, UK); DON, and DON3Glc in acetonitrile (Romer Labs, Runcorn, UK) and DOM-83 
1 in acetonitrile (Sigma-Aldrich Ltd, Poole, UK).       84 
 85 
Animals and ethical approval 86 
Five crossbred castrated male pigs, weaned at four weeks were bred in the animal facility of 87 
the INRA ToxAlim Laboratory (Toulouse, France). The experiment was conducted under the 88 
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authorization of the French ministry of Higher Education and Research after approval by the 89 
Ethics committee of Pharmacology-Toxicology of Toulouse-Midi-Pyrénées (Toxcométhique, 90 
N°: TOXCOM/0163 PP), in accordance with the European Directive (2010/63/EU) on the 91 
protection of animals used for scientific purposes. Feed and water were provided ad libitum 92 
throughout the experimental period. Pigs were fed for 4 days with starter diet and then with a 93 
commercial diet "STIMIO" for growing pigs (Evialis, Longue Jumelles, France), the feed 94 
composition is summarized in Table 1. As the presence of antibiotics or probiotics in feed can 95 
alter the composition of the luminal and mucosa-associated microbiota [20] non-supplemented 96 
feed was used. Pigs were maintained until 57 days of age as the pig intestinal flora is stable 97 
between at least 48 and 70 days of age [21]. Then, they were subjected to electronarcosis and 98 
euthanized by exsanguination [22]. The intestinal tract was removed from each carcass and 99 
sections of the jejunum, ileum, caecum and colon were dissected. Five millilitres of intestinal 100 
digesta content from each gut section was collected separately into sterile Wheaton bottles. 101 
Feces (5 mL) was sampled directly from the pen. Ten mL of a sterile mixture of 70% phosphate 102 
buffered saline (pH 7.4) /30% glycerol bubbled with CO2 were added into each vial. Vials were 103 
sealed and the headspace flushed with CO2 before being stored at -20°C. 104 
 105 
Microbial batch culture experiments  106 
After defrosting and vortexing, 15 mL of slurry were centrifuged at 2000 × g for 5 minutes. 107 
Supernatant was discarded and the remaining pellet was purged with CO2. At this stage, two 1 108 
mL aliquots were removed from each sample and stored in sample Matrix tubes at -70°C for 109 
subsequent DNA extraction. The remaining slurry was diluted 1/10 with anaerobic M2 medium 110 
as described before [10], placed in a shaking water bath (37°C, 100 rpm) in a sealed Wheaton 111 
bottle for 1 hour and 1 mL aliquots were moved to sterile screw-capped Hungate tubes. Slurry 112 
aliquots were spiked with individual mycotoxins (2 nmol/mL of DON, DON3Glc or DOM-1) 113 
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and incubated anaerobically at 37°C for intervals between 0-72 hours. This wide range of 114 
incubation times was chosen to reflect both the short transit time in the small intestine (early 115 
time points) and the long transit time in the large intestine (late time points). Following 116 
incubation, 3 mL acetonitrile were added to each sample and samples were centrifuged for 5 117 
minutes at 2000 × g. Supernatants were evaporated under N₂ at 50°C, reconstituted with 1 mL 118 
of water and passed through C18 solid phase extraction columns (Agilent, Wokingham, UK). 119 
Samples were eluted with 3 mL methanol, evaporated under N₂ at 50°C, reconstituted into 1 120 
mL of 50% aqueous methanol, and analysed for DON, DON3Glc and DOM-1 using LC-121 
MS/MS. Blank digesta incubations (omitting spiking with mycotoxins) were included in each 122 
experiment to ensure that all digesta samples were free of mycotoxin residues. Furthermore, 123 
DON3Glc or DON (2 nmoles/mL) were spiked individually into bacteria-free M2 culture 124 
media (in duplicates) and incubated for 72 hours to ensure stability of DON3Glc and DON 125 
under incubation conditions in the absence of bacteria. Both compounds were stable with 126 
recoveries of 100.7± 4.7% and 102.8± 1.9%, respectively after 72 hours. To further assess 127 
DON stability during incubation, digesta samples were spiked with DON (2 nmoles/mL) and 128 
incubated for 0 to 72 hours. This experiment showed no mass loss of DON (recovery up to 129 
119% of dose added), suggesting no binding of DON or further metabolism by microbes or 130 
any other digesta constituents. Each experiment also included digesta controls (in duplicate) 131 
spiked with DON3Glc, DON or DOM-1 individually, which were not incubated and 132 
immediately processed further (i.e. time 0) to account for potential matrix effects in mycotoxin 133 
detection. Mycotoxins detected in time 0 samples were set as 100% and all other results were 134 
calculated as % of time 0. 135 
 136 
QPCR analysis of microbial composition 137 
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Microbiota composition was analyzed using DNA extracted from untreated digesta samples 138 
(without mycotoxin spiking) derived from ileum, caecum, colon and feces of experimental 139 
pigs. Jejunal samples did not yield sufficient DNA to perform qPCR analysis.  DNA was 140 
extracted from 1 mL of digesta slurry using the FastDNAᵀᴹ Kit for Soil, (MP Biomedicals, 141 
Santa Ana, CA, USA) following the manufacturers’ instructions, and quantified using 142 
Qubit®dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). QPCR was 143 
performed using primers described in Table 2. The quantification of total bacteria, Prevotella 144 
spp., Bacteroides spp., Ruminococcaceae, Lachnospiraceae and Negativicutes, Lactobacillus 145 
spp., enterobacteria and bifidobacteria was performed as described before [24] using a Bio-146 
Rad CFX384 Real Time system and Bio-Rad CFX Manager Software 3.0 (Bio-Rad 147 
Laboratories, Watford, UK). DNA concentrations were standardised to 1 ng per well and 148 
standard curves consisted of dilution series of amplified bacterial 16S rRNA genes from 149 
reference strains as described previously [30]. Samples and standards were run in duplicate and 150 
5 ng/µL Herring Sperm DNA (Promega, Southampton, UK) was included in all reactions for 151 
stabilization. The efficiencies of standard curves ranged from 92.6 – 104.7% and R2 values 152 
ranged from 0.993 – 0.999 across all primers used. 153 
 154 
LC-MS/MS analysis  155 
The liquid chromatography analysis of the mycotoxins was performed on an Agilent 1200 156 
HPLC system (Agilent Technologies, Wokingham, UK) fitted with an Agilent Zorbax 5 µm, 157 
150 mm × 4.6 mm C18 column. The method parameters were described previously [10]. 158 
Mycotoxins were detected on a Q-Trap 4000 triple quadrupole mass spectrometer (AB Sciex, 159 
Warrington, UK) fitted with a Turbo Ion Spray™ (TIS) source. The transitions for DON, 160 
DOM-1 and DON3Glc from microbial incubations were: 355.1 → 265.1, 339.1 → 249.1 and 161 
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517.3 → 427.3, respectively. Calibration curves for each metabolite ranged from 0.25 to 2 162 
nmol/mL. 163 
 164 
Statistical analysis 165 
The time course over 72 hours of the DON and DON3Glc hydrolysis results from Figure 1 166 
(expressed as % of dose) were used to calculate the area under the curve (AUC, % × hr) for 167 
each animal and each intestinal section individually. Bacterial count data were log-168 
transformed to meet requirements of constant variance and normality (based on visual 169 
inspection of residual plots). These data were then analysed by ANOVA, with animal as 170 
random effect and tissue as fixed effect. When the effect of tissue was significant (P<0.05), 171 
tissues were compared by post hoc t-test based on the ANOVA output.  The colon sample of 172 
one animal was excluded from the statistical analyses due to failure of the qPCR assay. All 173 
analyses were carried out using Genstat 17 Release 17.1 (Lawes Agricultural Trust, VSN 174 
international Ltd, Hemel Hempstead, UK). A P-value < 0.05 was regarded significant. 175 
Results are presented as mean±SEM, based on spread between animals. 176 
 177 
Results  178 
This study was conducted to assess the metabolism of DON and DON3Glc by porcine 179 
microbiota derived from different regions of the intestinal tract. Results show that 180 
detoxification of DON to DOM-1 did not occur in any animal or any gut region (Table 3). No 181 
trace of DOM-1 was detectable in any of the samples (data not shown), and recovery of DON 182 
ranged from 87-119% of dose following incubation over 24-72 hours.  183 
Microbial hydrolysis of DON3Glc was efficient in all pigs and occurred at all intestinal 184 
regions tested (Figure 1). In the jejunum, DON3Glc hydrolysis was slowest and free DON was 185 
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first observed after 24 hours of incubation, increasing to a maximum of 1–41% of the added 186 
DON3Glc dose after 72 hours. The ileal microbiota was more efficient in DON3Glc hydrolysis 187 
releasing 60±18% of the dose as free DON after 24 hours of incubation. Microbiota of the large 188 
intestine hydrolyzed DON3Glc more rapidly with 2 and 3% of the dose detectable as free DON 189 
in caecum and colon incubations after 2 hours increasing to 8 and 14% after 6 hours of 190 
incubation. Fecal microbiota were most efficient in hydrolyzing DON3Glc with only 4±6% of 191 
the dose left as DON3Glc after 9 hours of incubation. 192 
The results from the DON3Glc hydrolysis time course experiments (Figure 1) were 193 
used to calculate the area under the curve (AUC) for each individual animal and each intestinal 194 
region for DON3Glc (Figure 2, top panel) and DON (bottom panel). DON3Glc hydrolysis rates 195 
were slowest for all animals in jejunal samples, as indicated by the highest AUC for DON3Glc 196 
curves and the lowest AUC for DON curves. Ileal DON3G hydrolysis was significantly faster 197 
in all animals (P<0.05) than jejunal hydrolysis, but slower (P<0.05) than rates observed in the 198 
large intestine. No differences were observed between DON3Glc hydrolysis rates in caecum, 199 
colon and fecal samples. 200 
Microbiota composition was analyzed using DNA extracted from untreated digesta 201 
samples (without mycotoxin spiking) derived from ileum, caecum, colon and feces of 202 
experimental pigs. Total bacterial load showed a tendency (P=0.057) towards differences 203 
between intestinal regions, with a lower log count in the ileum compared to the caecum and 204 
colon (P<0.05) (Figure 3). Log counts of Bacteroides spp., Prevotella spp., Ruminococcaceae, 205 
Lachnospiraceae and Negativicutes were all lower in the ileum (P<0.05) but did not differ 206 
between caecum, colon and feces. In the ileum members of the phylum Firmicutes dominated 207 
the microbiota with lactobacilli forming the largest portion of bacteria. However, most bacteria 208 
in the ileum were not identified with the primers used, suggesting that the ileum harbors 209 
bacteria out with the groups covered here. 210 
 o
n
 N
ovem
ber 6, 2017 by University of Aberdeen
http://aem
.asm
.org/
D
ow
nloaded from
 
10 
 
 211 
Discussion 212 
The current study was conducted to assess the microbial metabolism of the masked mycotoxin 213 
DON3Glc and the free form DON by intestinal microbiota derived from different regions of 214 
the small and large intestine of pigs. We found no evidence of microbial de-epoxydation of 215 
DON to DOM-1 in any digesta sample. Similarly, Eriksen and colleagues found no DOM-1 216 
production in ileal or fecal samples from 5 experimental pigs even though DOM-1 production 217 
was reported in pigs from commercial farms [14]. Interestingly, 4 of these 5 animals acquired 218 
the microbiota capable of DOM-1 production after they were exposed to feces of DOM-1 219 
producing animals.  This suggests that the microbes capable of DON de-epoxydation are 220 
acquired from the environment and confirms that ingestion of DON-contaminated feed may 221 
alter the intestinal microbiota [31,32]. 222 
The study presented here demonstrates that microbiota derived from the porcine small 223 
intestine efficiently hydrolyze the masked mycotoxin DON3Glc and release free DON in vitro. 224 
Furthermore, microbiota from the porcine caecum, colon and feces hydrolyze DON3Glc 225 
equally efficiently. Upon ingestion, DON3Glc has been found to be not toxic (in pig intestinal 226 
explants [8]) and is not absorbed intact in pigs, but free DON and further metabolites are 227 
detectable in plasma and urine.  DON3Glc absorption in pigs (as DON) is less efficient 228 
compared to free DON (16% vs 81% of dose absorbed after 8 hours [19]) and also slower than 229 
DON (42 vs 84% of dose excreted in urine after 24hours [18]). These findings suggest 230 
continuous, slow release of DON from DON3Glc prior to absorption, which would be in line 231 
with microbial hydrolysis beginning after 6 or 9 hours incubation as reported here.  232 
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This slow and continuous DON release from DON3Glc exposure may result in 233 
toxicities in the more distal regions of the intestine compared to DON dosed animals. There is 234 
some evidence that binding of DON to a clay-based feed additive results in DON exerting its 235 
intestinal toxicity (disruption of intestinal barrier function, induction of oxidative stress) in the 236 
more distal part of the small intestine in chickens when compared to free DON, although 237 
colonic tissue was not evaluated in this study [33]. This suggests that binding of DON can lead 238 
to the intestinal toxicity being shifted to more distal intestinal regions and it can be 239 
hypothesized that plant-bound DON3Glc could act as delivery mechanism to the ileum and 240 
colon where microbial hydrolysis will lead to DON exposure and potential toxicity. Upon 241 
ingestion of DON3Glc, it would be interesting to determine the absorption and the effect of 242 
DON in the large intestine. 243 
Microbiota profiling demonstrated that microbiota from the caecum, colon and feces 244 
were dominated by Prevotella spp., followed by Ruminococcaceae, Lachnospiraceae and 245 
Negativicutes. This is in agreement with literature suggesting Bacteroidetes and Fimicutes to 246 
be the dominant phyla in the large intestine and feces of pigs [34-36]. Enterobacteria 247 
represented a substantial group in the small and large intestine of only one pig, whereas 248 
Bacteroides spp. and bifidobacteria did not represent major groups in any animal or gut site. 249 
This is in contrast with published work [37] reporting Bacteroides spp. to be a major group in 250 
porcine feces. The current study focused on quantitative and qualitative analysis of the 251 
intestinal microbiota of the porcine intestine, but did not identify specific bacterial groups 252 
involved in the hydrolysis of DON3Glc. Published work  has identified bacteria from very 253 
different genera and phyla (lactobacilli, enterococci, bifidobacteria) that are capable of 254 
hydrolyzing DON3Glc and other masked mycotoxins [38,39] and future studies are required 255 
to understand their contribution to hydrolysis is mixed microbial communities and in vivo. 256 
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The human intestinal microbiota possess several glycosyl hydrolase genes [40] and 257 
human fecal microbiota are known to hydrolyse DON3Glc [7,10,11]. It is therefore likely that 258 
DON3Glc hydrolysis occurs in the human inestine, but future experiments are required to 259 
provide evidence. The fact that the microbial metabolite DOM-1 is present in human urine 260 
[10,16,17] further supports the hypothesis that microbial mycotoxin metabolism and absorption 261 
occur in vivo in humans.    262 
In conclusion, the present study demonstrates that masked mycotoxins can contribute 263 
to mycotoxin exposure following rapid, efficient and non-specific hydrolysis by intestinal 264 
microbiota of the distal small intestine and the large intestine. Potential specific toxicities of 265 
microbial mycotoxin release in the distal intestine remain to be investigated in future studies. 266 
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Figure legends 406 
 407 
Figure 1. Hydrolysis of DON3Glc and release of free DON by porcine intestinal microbiota 408 
form different regions of the small and large intestine over 0–72 hours. Results are presented 409 
as average of 5 animals±SEM. 410 
 411 
Figure 2. Individual differences in DON3Glc hydrolysis (top panel) and DON release (bottom 412 
panel) by intestinal microbiota of 5 animals. Data from time course experiments were 413 
summarized by area under the curve (AUC) for each individual animal and gut site. Effect of 414 
tissue was significant (P<0.001, ANOVA) for both DON3Glc and DON. Tissues that do not 415 
share a superscript are significantly different (P<0.05, post-hoc t-test). 416 
 417 
Figure 3. Microbial community analysis in porcine digesta samples from different regions of 418 
the small and large intestine. Results are presented as averages of 5 animals±SEM for ileum, 419 
caecum and feces and average of 4 animals±SEM for colon samples. Within those bacterial 420 
groups for which the effect of tissue was significant (P<0.05, ANOVA), tissues that do not 421 
share a superscript are significantly different (P<0.05). 422 
  423 
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Table 1. Summary of feed composition. 424 
Food constituent Unit Oligo elements  mg/kg 
Raw proteins 17 % Iron 86 
Raw fat 2.5 % Copper  160 
Raw ashes 4.5 % Manganese 40 
Crude fiber 4.5 % Zinc 110 
Phosphorus 0.55 % Iodine 1 
Calcium 0.65 % Selenium 0.3 
Sodium 0.2 %   
Lysine 11.9 g/kg   
Methionine 3.6 g/kg   
Additives Units/kg Enzymes  Units/kg 
E672 A vitamin  12000 Endo 1, 3 (4) beta glucanase 125 U 
E671 D3 vitamin  2000 Endo 1, 4 beta xylanase 87 U 
3a700 E vitamin E 60 Phytase 1880 U 
 425 
 426 
 427 
  428 
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Table 2. Summary of group-specific qPCR primers. 429 
Target group Sequence T Amplicon Reference 
strain 
Ref. 
Universal GTGSTGCAYGGYYGTCGTCA 60 141 Ruminococcus 
bromii L2-63  
[23] 
ACGTCRTCCMCNCCTTCCTC 
Prevotella spp. CRCRCRGTAAACGATGGATG 65 105 Prevotella copri 
DSM18205  
[24] 
TTGAGTTTCACCGTTGCCGG 
Bacteroides spp. GCTCAACCKTAAAATTGCAGTTG 63 110 Bacteroides 
thetaiotamicron 
B5482  
 
[24] GCAATCGGRGTTCTTCGTG 
Lactobacillus spp. AGCAGTAGGGAATCTTCCA 60 341 Lactobacillus 
reuteri 
DSM20016  
[25] 
CACCGCTACACATGGAG [26] 
Bifidobacteria TCGCGTCYGGTGTGAAAG 60 128 Bifidobacterium 
adolescentis 
DSM20083  
[23] 
GGTGTTCTTCCCGATATCTACA 
 
Enterobacteria GACCTCGCGAGAGCA 60 180 Escherichia coli 
XL1Blue  
[27] 
CCTACTTCTTTTGCAACCCA 
Cluster IV 
Ruminococcaceae 
family 
GCACAAGCAGTGGAGT1 60 241 R. bromii L2-63  [28] 
GCACAAGCGGTGGATT1 
CTTCCTCCGTTTTGTCAA 
Cluster IX 
Negativicutes 
class 
GTTGTCCGGAATYATTGGGC 63 321 Megasphaera 
elsdenii LC1  
[29] 
ATTGCGTTAACTCCGGCACA2 
ATTGCGTTAACTCCGGCACG2 
Cluster XIVa 
Lachnospiraceae 
family 
CGGTACCTGACTAAGAAGC 60 429 Roseburia 
hominis A2-183  
[30] 
AGTTTYATTCTTGCGAACG 
Both primers (1forward primers for cluster IV, 2reverse primers for cluster IX primers) were 430 
used together at equimolar concentration. T Annealing temperature. 431 
 432 
 433 
 434 
 435 
  436 
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Table 3. Recovery (% of dose 2 nmol/mL) of DON from microbial incubations.  437 
Time Jejunum Ileum Caecum Colon Feces 
0 hr 100.3 (±0.3) 102.7 (±1.2) 98.6 (±1.1) 100.5 (±0.3) 99.9 (±0.1) 
24 hr 103.9 (±6.7) 97.2 (±8.4) 94.0 (±9.3) 99.6 (±8.3) 119.4 (±5.7) 
48 hr 87.3 (±4.3) 90.0 (±6.1) 113.9 (±6.2) 103.9 (±9.3) 114.6 (±8.7) 
72 hr 90.3 (±6.2) 91.8 (±6.6) 116.0 (±6.5) 108.1 (±9.0) 113.6 (±7.8) 
Results presented as average of 5 animals±SEM. 438 
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